| scholarly article | Q13442814 |
| P50 | author | Kristina R. Dahlstrom | Q46732986 |
| P2093 | author name string | Qingyi Wei | |
| Chong Zhao | |||
| Guojun Li | |||
| Erich M Sturgis | |||
| Caroline S Hussey | |||
| Jenny T Vo | |||
| P2860 | cites work | Biomarkers of HPV in head and neck squamous cell carcinoma. | Q36295974 |
| Human papillomavirus detection in head and neck squamous cell carcinomas. | Q37802139 | ||
| Human papillomavirus DNA in sera of cervical cancer patients as tumor marker | Q44500775 | ||
| Beyond cervical cancer: burden of other HPV-related cancers among men and women | Q44737179 | ||
| Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience | Q45284350 | ||
| Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels | Q45354343 | ||
| Clinical significance of plasma Epstein-Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma | Q45356539 | ||
| Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma | Q45629039 | ||
| Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma | Q45665252 | ||
| Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. | Q45742381 | ||
| Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma | Q45746414 | ||
| Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma | Q45750458 | ||
| Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials | Q46497166 | ||
| Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer | Q46591017 | ||
| Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma | Q46606440 | ||
| Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia | Q47257373 | ||
| A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. | Q51908580 | ||
| The role of human papillomavirus in the increased incidence of base of tongue cancer. | Q54457505 | ||
| Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma | Q57950999 | ||
| Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma | Q59647308 | ||
| Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma | Q77559024 | ||
| HPV DNA in plasma of patients with cervical carcinoma | Q80822306 | ||
| Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States | Q22306233 | ||
| Human papillomavirus DNA in plasma of patients with cervical cancer | Q24798417 | ||
| Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 | ||
| Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 | ||
| Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. | Q33181502 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population | Q34286259 | ||
| Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma. | Q34439008 | ||
| HPV: from infection to cancer | Q34716560 | ||
| Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Q34749494 | ||
| Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? | Q34971126 | ||
| Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. | Q35038194 | ||
| Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. | Q35152720 | ||
| Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients | Q35670356 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3455-3464 | |
| P577 | publication date | 2015-06-19 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer | |
| P478 | volume | 121 |
| Q91739487 | A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma |
| Q91694363 | Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma |
| Q89574572 | Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis |
| Q91950795 | Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer |
| Q37456554 | Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma |
| Q99616869 | Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond |
| Q39191687 | Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era. |
| Q93110798 | Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy |
| Q64899007 | Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). |
| Q57812823 | Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples |
| Q90682083 | HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles |
| Q64060941 | HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study |
| Q90664639 | Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers |
| Q89879669 | Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma |
| Q65002389 | Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer. |
| Q40082592 | Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma |
| Q64119039 | Putative Role of Circulating Human Papillomavirus DNA in the Development of Primary Squamous Cell Carcinoma of the Middle Rectum: A Case Report |
| Q46015106 | Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer. |
| Q89634843 | Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer |
| Q54254993 | The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma. |
| Q95582765 | The potential for liquid biopsies in head and neck cancer |
| Q40081693 | The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma |
Search more.